Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032

Overview

The Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market is expected to reach a 62.66 USD Million by 2032 and is projected to grow at a CAGR of 9.27% from 2025 to 2032.

Revenue, 2024 (USD Million)

30.86

Forecast, 2032 (USD Million)

62.66

CAGR, 2024 - 2032

9.27%

Report Coverage

Middle East & Africa

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market 2018-2032 USD Million

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market, Key Findings (2025-2032)

Market Growth and Projections:

Market Size (2024): 30.86 USD Million
Projected Market Size (2032): 62.66 USD Million
CAGR (2025-2032): 9.27%

Key Findings of Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market

The Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at 30.86 USD Million in 2024.
The Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market is likely to grow at a CAGR of 9.27% during the forecast period of 2024 to 2032.
In 2024, the Largest segment Beta Emitters in Isotope Segment accounted for the largest share of the market with a revenue of 27.43 USD Million
The fastest growing segment Small Molecule Ligands in Vector Type Segment grew Fastest with a CAGR of 9.74% during the forecast period from 2024 to 2032.

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Scope

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Segmentation & Scope

Isotope

Alpha Emitters
Beta Emitters

Sources

Others
Generator-Produced Isotopes
Reactor-Produced Isotopes

Therapeutic Application

Others
Oncology

End User

Research Institutes
Radiopharmacies
Hospitals

Vector Type

Others
Monoclonal Antibodies
Peptides
Small Molecule Ligands

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Data Coverage Insights

Study Period	2024-2032
Base Year	2024
Unit	Revenue in USD Million
Market Value in 2024	30.86 USD Million
Market Value in 2032	62.66 USD Million
CAGR (2025-2032)	9.27%
Historic Data	2016-2023
Market Segments Covered	Isotope,Sources,Therapeutic Application,End User,Vector Type

Regional Insights:

Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 30.86 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 8.17 USD Million in 2024.

Segments and Scope

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Isotope
- Beta Emitters is the largest segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 27.43 USD Million in the year 2024.
- Beta Emitters is the Fastest growing segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 9.29 % in forecast period 2025-2032.
Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Sources
- Reactor-Produced Isotopes is the largest segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 20.01 USD Million in the year 2024.
- Reactor-Produced Isotopes is the Fastest growing segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 9.37 % in forecast period 2025-2032.
Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Therapeutic Application
- Oncology is the largest segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 24.28 USD Million in the year 2024.
- Oncology is the Fastest growing segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 9.55 % in forecast period 2025-2032.
Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 18.57 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 9.37 % in forecast period 2025-2032.
Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032, By Vector Type
- Small Molecule Ligands is the largest segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a revenue of 17.09 USD Million in the year 2024.
- Small Molecule Ligands is the Fastest growing segment in Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market to 2032 with a Growth rate of 9.74 % in forecast period 2025-2032.

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Share Analysis

Company Name
Novartis AG
Eckert & Ziegler
ITM Isotope Technologies Munich SE
SHINE Technologies, LLC

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Geographical Sales Distribution, 2018-2032 USD Million

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market

Middle East & Africa Cold Sore Treatment Market

North America Cold Sore Treatment Market

Europe Cold Sore Treatment Market

Asia-Pacific Cold Sore Treatment Market

Argentina Cold Sore Treatment Market

Australia Cold Sore Treatment Market

Austria Cold Sore Treatment Market

Belgium Cold Sore Treatment Market

Brazil Cold Sore Treatment Market

Frequently Asked Questions

What are the primary segments covered in the Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market is segmented based on Segmentation Isotope,Sources,Therapeutic Application,End User,Vector Type.

What is the current market size of the Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market?

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market was valued at USD 30.86(Revenue in USD Million) in 2024.

What is the expected growth rate of the Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market?

Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market is projected to grow at a CAGR of 9.27% during the forecast period of 2024 to 2032.

Which is the dominating segment in the Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market?

The Beta Emitters segment is expected to dominate the Middle East & Africa Alpha and Beta Emitters Based Radiopharmaceuticals Market, holding a largest market share of 27.43 USD Million in 2024